Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities

Annual Review of Public Health - Tập 39 Số 1 - Trang 525-541 - 2024
Dennis McCarty1,2, Kelsey C. Priest3,2, P. Todd Korthuis4,2
1Department of Psychiatry, School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, USA
2Oregon Health & Science University–Portland State University School of Public Health, Portland, Oregon 97239, USA;, ,
3MD/PhD Program, School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, USA
4Addiction Medicine Section, Department of Medicine, School of Medicine, Oregon Health & Science University, Portland, Oregon 97239, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.2105/AJPH.2016.303558

10.1016/j.jsat.2015.10.003

10.1111/j.1526-4637.2011.01128.x

10.1001/archinternmed.2010.541

ASAM (Am. Soc. Addict. Med.)., 2013, The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions

10.1056/NEJMp1108649

10.1056/NEJMe0904243

Besteman KJ, 1992, Treating Drug Problems: Volume 2, 63

10.1097/ADM.0000000000000310

10.1377/hlthaff.2011.0480

Campbell ND, 2008, The Narcotic Farm: The Rise and Fall of America's First Prison for Drug Addicts

12. CDC (Cent. Dis. Control Prev.) Health Advis. 2015. Increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. CDCHAN-00384, Oct. 26, CDC Health Alert Netw. Atlanta. https://emergency.cdc.gov/han/han00384.asp

CMS (Cent. Medicare Medicaid Serv.)., 2016, Fed. Regist., 81, 27498

Courtwright D, 1989, Addicts Who Survived: An Oral History of Narcotic Use in America, 1923–1965

Courtwright DT, 1982, Dark Paradise: Opiate Addiction in America Before 1940

16. De Leon G, Rosenthal MS. 1979. Therapeutic communities. See Ref. 25, pp. 39–47

10.1016/j.drugalcdep.2010.07.023

10.1377/hlthaff.2012.0945

Divers. Control Div., 2017, Controlled substance schedules

10.1001/jama.1965.03090080008002

10.1001/archinte.1966.00290160004002

10.1001/jama.2016.1464

Dowell D, 2016, MMWR, 65, 1, 10.15585/mmwr.su6503a1

Drug Enforc. Adm. Off. Divers. Control., 2006, Practitioner's Manual: An Informational Outline of the Controlled Substances Act

Dupont RI, 1979, Handbook on Drug Abuse

10.1080/10550490701860971

10.1056/NEJMcp013579

10.1056/NEJMoa055255

10.1081/ADA-120002972

10.1097/QAI.0b013e3182097537

10.1056/NEJMp1700834

10.1111/j.1749-6632.2010.05900.x

Gourevitch MN, 2005, Substance Abuse: A Comprehensive Textbook, 4, 840

10.1056/NEJMp1609578

10.1001/archpsyc.58.5.503

Hughes A, 2016, Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health

Inst. Med., 1990, Treating Drug Problems, 1

Inst. Med., 1995, Federal Regulation of Methadone Treatment

Inst. Med., 1997, Managing Managed Care: Quality Improvement in Behavioral Health

Jaffe JH, 1997, NIH Consens. Dev. Conf. Statement: Effective Medical Treatment of Heroin Addiction, 17

10.1016/S0376-8716(03)00055-3

10.1001/archpsyc.1978.01770280111012

Joseph H, 2000, Mt Sinai J. Med., 67, 347

Julius D, 1976, Narcotic Antagonists: Naltrexone. Progress Report, 5

10.1097/ADM.0000000000000166

10.1186/s13722-016-0068-3

10.1016/S0140-6736(10)60544-2

10.1016/S0140-6736(05)66475-6

10.1016/j.evalprogplan.2011.02.004

10.1097/ADM.0b013e3181d41ddb

10.1097/ADM.0b013e318262a97a

10.1146/annurev-publhealth-031914-122957

10.1080/08897077.2015.1129388

10.7326/M16-2149

10.1016/S0740-5472(02)00259-3

10.1016/S0140-6736(11)60358-9

10.1016/j.jsat.2015.06.010

10.1377/hlthaff.2016.0394

Leukefeld CG, 1991, Improving Drug Abuse Treatment, 328

10.1177/002204268801800406

10.1016/S0140-6736(10)62353-7

10.1016/j.jsat.2014.07.012

Minist. Health., 1926, Rolleston Report: Departmental Committee on Morphine and Heroin Addiction

Minozzi S, 2011, Cochrane Database Syst. Rev., CD001333

10.1056/NEJMp1612578

Musto DF, 1973, The American Disease: Origins of Narcotic Control

10.1503/cmaj.110669

Off. Assist. Secr. Plan. Eval., 2015, Opioid abuse in the U.S. and HHS actions to address opioid-drug related overdoses and deaths.

69. Off. Mo. Gov. Eric Greitens. 2017. Governor Eric Greitens announces statewide prescription drug monitoring program. News Release, July 17.https://governor.mo.gov/news/archive/governor-eric-greitens-announces-statewide-prescription-drug-monitoring-program

Off. Natl. Drug Control Policy., 2011, Epidemic: Responding to America's Prescription Drug Abuse Crisis

Off. Surg. Gen., 2016, Facing Addiction in America: The Surgeon General's Report on Alcohol Drugs and Health

10.1056/NEJMoa0810635

10.15585/mmwr.mm6533a3

74. Phillips KA, Friedmann PD, Saitz R, Samet JH. 2014. Linking addiction treatment with other medical and psychiatric treatment systems. See Ref. 79, pp. 442–55

75. Proj. Lazarus. 2017. The Project Lazarus model. Proj. Lazarus, Moravian Falls, NC.https://www.projectlazarus.org/the-model

Prov. Opioid Use Disord. Treat. Guidel. Comm., 2017, A Guideline for the Clinical Management of Opioid Use Disorder

77. Resnick RB, Schuyten-Resnick E, Washton AM. 1979. Treatment of opioid dependence with narcotic antagonists. See Ref. 25, pp. 97–104

10.1377/hlthaff.2016.0347

Ries RK, 2014, The ASAM Principles of Addiction Medicine, 5

10.15585/mmwr.mm655051e1

81. Saitz R. 2014. Medical and surgical complications of addiction. See Ref. 79, pp. 1067–89

SAMHSA (Subst. Abuse Mental Health Serv. Adm.)., 2017, National Survey of Substance Abuse Treatment Services (N-SSATS): 2016. Data on Substance Abuse Treatment Facilities.

SAMHSA (Subst. Abuse Mental Health Serv. Adm.)., 2017, Treatment Episode Data Set (TEDS): 2005–2015. National Admissions to Substance Abuse Treatment Services.

Somerville NJ, 2017, MMWR, 66, 382

10.1186/1940-0640-10-S1-A63

UNODC (UN Off. Drugs Crime), WHO (World Health Organ.)., 2017, International Standards for the Treatment of Drug Use Disorders

87. US CMS (Cent. Medicare Medicaid Serv.). 2017. Letter to C. Beane, Oct. 6. CMS, Washington, DC. https://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/Waivers/1115/downloads/wv/wv-creating-continuum-care-medicaid-enrollees-substance-ca.pdf

US Dep. HHS (Health Hum. Serv.)., 2016, The Mental Health and Substance Use Disorder Parity Task Force: Final Report

89. Vestal C. 2017. States seek Medicaid dollars for addiction treatment beds. Stateline April 5.http://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2017/04/05/states-seek-medicaid-dollars-for-addiction-treatment-beds

10.1056/NEJMsr1706626

Wachino V, 2015, Re: New service delivery opportunities for individuals with a substance use disorder

10.1136/bmj.f174

Warner M, 2011, NCHS Data Brief, 1

10.1001/archgenpsychiatry.2011.121

10.1016/j.drugalcdep.2015.02.030

96. White W, Callahan JF. 2014. Addiction medicine in America: its birth and early history (1750–1935) with a modern postscript. See Ref. 79, pp. 365–74

White House Off. Press Secr., 2017, President Donald J. Trump signs an Executive Order establishing the President's Commission on Combating Drug Addiction and the Opioid Crisis

98. White House Off. Press Secr. 2017. Presidential Executive Order establishing the President's Commission on Combating Drug Addiction and the Opioid Crisis. News Release, March 29.https://www.whitehouse.gov/the-press-office/2017/03/30/presidential-executive-order-establishing-presidents-commission

Wood E, 2004, Harm Reduct. J., 13, 95

10.1503/cmaj.1040774